Trials / Recruiting
RecruitingNCT07516769
Nicorandil as Anti-inflammatory in Rheumatoid Arthritis
Clinical Study Evaluating the Effect of Nicorandil as Anti-inflammatory and Immune Modulatory in Patients With Rheumatoid Arthritis
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicorandil 10 MG Oral Tablet | Nicorandil 10 MG Oral Tablet |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2027-03-01
- Completion
- 2027-04-01
- First posted
- 2026-04-08
- Last updated
- 2026-04-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07516769. Inclusion in this directory is not an endorsement.